News | January 06, 2023
Lupin launches novel fixed-dose triple drug combination DIFIZMA DPI to treat Asthma
The estimated national burden of asthma in India is at 17.23 million with an overall prevalence of 2.05% and out of this, approximately 30 lakh patients can be classified under “inadequately controlled”
